Rare diseases
Investigational molecules
Locations
Back to Italy2 862 clinical trials in Saronno, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of N-Acetyl-GED-0507-34-LEVO gel 5% applied daily for treating acne vulgaris
ItalyStudy on the Effects of Sparsentan and Irbesartan for Patients with Primary Focal Segmental Glomerulosclerosis (FSGS)
ItalyLong-term Study of Sotatercept for Adults with Pulmonary Arterial Hypertension (PAH)
ItalyStudy on the Effectiveness and Safety of Golcadomide and Rituximab for Patients with Newly Diagnosed Advanced Follicular Lymphoma
ItalyStudy on the Effectiveness and Safety of Osimertinib for Patients with Early-Stage Non-Small Cell Lung Cancer After Tumor Removal
ItalyStudy of Berubicin versus lomustine in adult patients with recurrent Glioblastoma Multiforme after first-line treatment failure
ItalyStudy of Avutometinib and Defactinib for Patients with Recurrent Low-Grade Serous Ovarian Cancer
ItalyStudy of Drug Combination Treatment (Capecitabine, Oxaliplatin, Fluorouracil, Irinotecan) Guided by Liquid Biopsy Testing in Patients with Stage III and High-Risk Stage II Colon Cancer
ItalyStudy on the Safety and Effects of Temferon for Patients with Metastatic Renal Cell Carcinoma Using a Drug Combination
ItalyStudy on Fianlimab and Cemiplimab for Adults with Resectable Stage III and IV Melanoma
ItalyStudy on the Effectiveness and Safety of BAY 2927088 Compared to Standard Treatment in Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations
ItalyStudy Comparing Bomedemstat and Hydroxycarbamide for Patients with Essential Thrombocythemia
ItalyThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on non-small cell lung cancer (NSCLC) treatments, including studies evaluating novel therapeutic approaches for patients with specific genetic mutations.
Research emphasizes personalized treatment strategies for advanced and metastatic disease states.
Comprehensive studies addressing breast cancer and gynecological malignancies, with focus on treatment timing and maintenance therapies.
Investigations aim to optimize treatment sequences and improve patient outcomes.
Innovative research in renal cell carcinoma treatment and cardiac conditions, particularly focusing on novel therapeutic approaches.
Studies evaluate both oncological interventions and cardiovascular treatments for high-risk patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
